DELETIONS WITHIN THE LATENT MEMBRANE PROTEIN-1 ONCOGENE (LMP1) OF THE EPSTEIN-BARR-VIRUS (EBV) ARE CLUSTERED AND OCCUR EARLIER IN EVOLUTION THAN INSERTIONS

被引：0
|
作者：
KNECHT, H
BACHMANN, E
BROUSSET, P
SANDVEJ, K
ODERMATT, BF
DELSOL, G
PALLESEN, G
BACHMANN, F
机构：
[1] CHU VAUDOIS HOSP,LAUSANNE,SWITZERLAND
[2] UNIV HOSP ZURICH,INST PATHOL,CH-8091 ZURICH,SWITZERLAND
[3] CHU PURPAN,ANAT PATHOL LAB,TOULOUSE,FRANCE
[4] AARHUS KOMMUNE HOSP,IMMUNOHISTOL LAB,DK-8000 AARHUS,DENMARK
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A46 / A46
页数：1
相关论文
共 50 条
  • [21] Construction and activity of an intracellular single-chain antibody against the latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV).
    Piche, A
    Kasano, K
    Curiel, T
    Curiel, DT
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (04): : 118 - 118
  • [22] DETECTION OF EPSTEIN-BARR-VIRUS (EBV) LATENT MEMBRANE-PROTEIN (LMP) IN HODGKINS-DISEASE (HD)
    LONES, M
    PINKUS, G
    SHINTAKU, IP
    SAID, JW
    LABORATORY INVESTIGATION, 1993, 68 (01) : A95 - A95
  • [23] A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways
    Adriaenssens, E
    Mougel, A
    Goormachtigh, G
    Loing, E
    Fafeur, V
    Auriault, C
    Coll, J
    ONCOGENE, 2004, 23 (15) : 2681 - 2693
  • [24] Erratum: A novel dominant-negative mutant form of Epstein–Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways
    Eric Adriaenssens
    Alexandra Mougel
    Gautier Goormachtigh
    Estelle Loing
    Véronique Fafeur
    Claude Auriault
    Jean Coll
    Oncogene, 2004, 23 : 8184 - 8184
  • [25] Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma
    Siegler, G
    Kremmer, E
    Gonnella, R
    Niedobitek, G
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2003, 56 (03): : 156 - 161
  • [26] A DELETION MUTANT OF THE LMP1 ONCOGENE OF EPSTEIN-BARR-VIRUS IS ASSOCIATED WITH EVOLUTION OF ANGIOIMMUNOBLASTIC LYMPHADENOPATHY INTO B-IMMUNOBLASTIC LYMPHOMA
    KNECHT, H
    MARTIUS, F
    BACHMANN, E
    HOFFMAN, T
    ZIMMERMANN, DR
    ROTHENBERGER, S
    SANDVEJ, K
    WEGMANN, W
    HURWITZ, N
    ODERMATT, BF
    KUMMER, H
    PALLESEN, G
    LEUKEMIA, 1995, 9 (03) : 458 - 465
  • [27] A DELETION VARIANT OF THE LATENT MEMBRANE PROTEIN-I (LMP1) ONCOGENE OF EPSTEIN-BARR-VIRUS (EBV) IS ASSOCIATED WITH TRANSFORMATION OF ANGIOIMMUNOBLASTIC LYMPHADENOPATHY (AILD) INTO B-IMMUNOBLASTIC LYMPHOMA (B-IBL)
    KNECHT, H
    MARTIUS, F
    BACHMANN, E
    HOFFMANN, T
    ZIMMERMANN, D
    ROTHENBERGER, S
    SANDVEJ, K
    ODERMATT, BF
    PALLESEN, G
    BLOOD, 1994, 84 (10) : A521 - A521
  • [28] FREQUENT DETECTION OF EPSTEIN-BARR-VIRUS (EBV), EBEB TRANSCRIPTS AND LATENT MEMBRANE PROTEIN-1 (LMP-1) IN TUMOR-CELLS IN HODGKINS-DISEASE ARISING IN CHILDHOOD
    KANAVAROS, P
    SAKALIDOU, A
    TZARDI, M
    DARIVIANAKI, K
    DELIDES, G
    KAZLARIS, E
    KALMANTI, M
    PATHOLOGY RESEARCH AND PRACTICE, 1994, 190 (11) : 1026 - 1030
  • [29] Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas
    Kingma, DW
    Weiss, WB
    Jaffe, ES
    Kumar, S
    Frekko, K
    Raffeld, M
    BLOOD, 1996, 88 (01) : 242 - 251
  • [30] A Systematic Review of Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma
    Banko, Ana
    Miljanovic, Danijela
    Lazarevic, Ivana
    Cirkovic, Andja
    PATHOGENS, 2021, 10 (08):
12345